Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This study investigates how seizures can vary over time with changes in low grade gliomas and its treatments. This study may help doctors find symptoms or triggers of seizures earlier than normal, and ultimately earlier care or treatment for seizures.
Full description
PRIMARY OBJECTIVE:
I. To evaluate the rate of change of seizure frequency and the status of the tumor at each data collection point.
SECONDARY OBJECTIVES:
I. To obtain sufficient number of patients' data in order to power the analysis to determine whether a change in seizure frequency correlates with tumor control.
II. Evaluate progression free survival and overall survival when compared with seizure control.
OUTLINE:
Patients complete a seizure assessment survey over 5 minutes at each clinic visit.
Enrollment
Sex
Volunteers
Inclusion criteria
- Adult patients
- Primary brain tumors (separated by World Health Organization [WHO] grade I-IV)
- History of seizures secondary to brain tumor
- On tumor directed treatment
- Magnetic resonance imaging (MRI) within 2 weeks of clinic visit where seizure assessment takes place
Exclusion criteria
- Patients without seizures
- Patients with intracranial lesions other than primary brain tumor
- Patients not undergoing tumor directed treatment
- Absence of recent (within 2 weeks) MRI
Trial design
100 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Ashley Aaroe, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal